GENEVA, June 24 -- PHAROS IBIO CO., LTD filed a patent application (KR2025/020169) for “USE OF PYRIDO[3,4-D]PYRIMIDIN-8-ONE DERIVATIVE FOR PREVENTING, AMELIORATING OR TREATING LUNG CANCER”. With publication no. WO/2026/117094, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/519

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....